Table 2 Relationship between PSMC2 expression and tumor characteristics in patients with breast cancer.
Features | No. of patients | PSMC2 expression | P value | |
---|---|---|---|---|
Low | High | |||
All patients | 175 | 83 | 92 | Â |
Age (years) | Â | Â | Â | 0.072 |
 ≤60 | 108 | 56 | 52 |  |
 >60 | 59 | 22 | 37 |  |
Tumor size | Â | Â | Â | 0.020 |
 ≤3 cm | 87 | 45 | 42 |  |
 >3 cm | 59 | 19 | 40 |  |
Grade | Â | Â | Â | 0.006 |
 I | 1 | 0 | 1 |  |
 II | 81 | 45 | 36 |  |
 III | 67 | 21 | 46 |  |
T Infiltrate | Â | Â | Â | 0.347 |
 T1 | 42 | 22 | 20 |  |
 T2 | 100 | 45 | 55 |  |
 T3 | 14 | 5 | 9 |  |
 T4 | 1 | 1 | 0 |  |
Lymphatic metastasis (N) | Â | Â | Â | 0.238 |
 N0 | 85 | 37 | 48 |  |
 N1 | 42 | 19 | 23 |  |
 N2 | 21 | 12 | 9 |  |
 N3 | 12 | 7 | 5 |  |
AJCC Stage | Â | Â | Â | 0.637 |
 1 | 30 | 15 | 15 |  |
 2 | 88 | 37 | 51 |  |
 3 | 39 | 21 | 18 |  |
Lymphoid positive number | Â | Â | Â | 0.475 |
 =0 | 78 | 32 | 46 |  |
 >0 | 66 | 31 | 35 |  |